A systematic review of the effectiveness of patient-based educational interventions to improve cancer-related pain by Oldenmenger, W.H. (Wendy) et al.
Cancer Treatment Reviews 63 (2018) 96–103Contents lists available at ScienceDirect
Cancer Treatment Reviews
journal homepage: www.elsevierheal th.com/ journals /c t rvGeneral and Supportive CareA systematic review of the effectiveness of patient-based educational
interventions to improve cancer-related painhttps://doi.org/10.1016/j.ctrv.2017.12.005
0305-7372/ 2017 The Author(s). Published by Elsevier Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
⇑ Corresponding author at: Department of Medical Oncology, Erasmus MC Cancer
Institute, PO Box 5201, 3008 AE Rotterdam, The Netherlands.
E-mail addresses: w.h.oldenmenger@erasmusmc.nl (W.H. Oldenmenger),
j.i.geerling@umcg.nl (J.I. Geerling), i.mostovaya@kennisinstituut.nl (I. Mostovaya),
Kris.Vissers@radboudumc.nl (K.C.P. Vissers), A.deGraeff@umcutrecht.nl
(A. de Graeff), a.k.l.reyners@umcg.nl (A.K.L. Reyners), ymvanderlinden@lumc.nl
(Y.M. van der Linden).Wendy H. Oldenmenger a,⇑, Jenske I. Geerling b, Irina Mostovaya c, Kris C.P. Vissers d, Alexander de Graeff e,
Anna K.L. Reyners b, Yvette M. van der Linden f
aDepartment of Medical Oncology, Erasmus MC Cancer Institute, PO Box 5201, 3008 AE Rotterdam, The Netherlands
bDepartment of Medical Oncology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands
cKnowledge Institute of Medical Specialists, PO Box 3320, 3502 GH Utrecht, The Netherlands
dDepartment of Anesthesiology, Pain and Palliative Medicine, Radboud University Medical Center, Geer Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
eCancer Center University Medical Center-Utrecht, Department of Medical Oncology, University of Utrecht, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands
fDepartment of Radiotherapy, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands
a r t i c l e i n f o a b s t r a c tArticle history:
Received 13 November 2017
Accepted 8 December 2017
Keywords:
Cancer pain
Patient education
Systematic review
Pain intensity
Knowledge
Pain interferenceBackground: Despite existing guidelines to assess and manage pain, the management of cancer-related
pain is often suboptimal with patients often being undertreated. Inadequate pain management may be
due to patient-related barriers. Educating patients may decrease these barriers. However, the effect of
pain education on patient-related outcomes is still unclear. This review aimed to study the effect of edu-
cational interventions on cancer-related pain.
Design: We performed a systematic review of randomized controlled trials (RCTs) identified from
Medline and Cinahl, from 1995 to May 2017. Two reviewers independently selected trials comparing
educational intervention to usual care or an active control intervention. The methodological quality
was assessed and data extraction was done independently. Primary outcome measures were pain inten-
sity and interference. Secondary outcome measures were knowledge/barriers, medication adherence and
self-efficacy.
Results: Twenty-six RCTs totaling 4735 patients met our inclusion criteria. Compared to the control
group, 31% of the studies (including 19% of all patients) reported a significant difference in pain intensity
in favor of the intervention group. Twelve studies measured pain interference and four (30%) found a
significant improvement. With regard to secondary endpoints, significant differences in favor of the
experimental arms were found for pain knowledge or barriers (15/22 studies; 68%), medication
adherence (3/6 studies; 50%) and self-efficacy (1/2 studies).
Conclusions: Patient-based pain educational programs may result in improvements of relevant patient-
reported outcomes. However, the interventions are heterogeneous and improvement of pain was only
seen in less than one third of the studies and in less than 20% of all included patients.
 2017 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pain continues to be a frequently occurring symptom in
patients with cancer, with a prevalence of 66% in patients with
advanced, metastatic or terminal disease. In addition, 38% of all
patients with cancer-related pain report moderate or severe pain(5 on a 0–10 numeric rating scale) [1]. Pain is associated with
interference with daily activities, sleep, mood and social interac-
tions [2–4]. Despite existing guidelines to assess and manage pain
[5–7], the management of cancer-related pain is often suboptimal
[8] and patients are regularly undertreated [9]. Inadequate pain
management seems to be related to professional as well as
patient-related barriers. The most commonly reported
professional-related barriers include inadequate assessment and
inadequate knowledge of pain management. The three most fre-
quently described patient-related barriers are: poor knowledge
and misconceptions about pain medication and their side-effects,
non-adherence to treatment regimens and a deficit in communica-
tion about pain with health care providers [2,10]. Different
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improve their knowledge and communication with healthcare pro-
fessionals have been developed and studied. Because these inter-
ventions vary greatly in type, content and duration the effects
are still uncertain [3,10–12]. Moreover, it remains unclear which
intervention components are most effective to improve cancer pain
management [3,10–14].
In the Netherlands we recently updated our national evidence-
based guideline ‘‘Diagnostics and treatment of pain in patients
with cancer” [7]. As part of this guideline update, the literature
on the effectiveness of educational interventions was systemati-
cally reviewed, since various new randomized controlled trials
(RCTs) were published in the last 7 years and the existing reviews
did not report all possible relevant outcomes. It was hypothesized
that educating patients about pain improves their knowledge,
reduces pain-related barriers and improves medication adherence
and self-efficacy, which will all lead to better pain control and
less interference with daily life [15]. The aim of this systematic
review is to investigate the effectiveness of educational interven-
tions in patients with cancer-related pain on all these relevant
outcomes.Materials and methods
Search methods
A systematic search of the literature published between January
1st 1995 and May 8th 2017 was performed using the following
databases: Medline (OVID) and Cinahl. Together with a literature
search specialist (IM), we developed a comprehensive search strat-
egy combining key terms using a series of free text terms and
MESH terms for: profession and/role (e.g. nurse; nurse practi-
tioner; cancer nurse; oncology nurse) and Cancer (e.g. neoplasm;
tumor, etc.). Boolean operators were used in order to maximize
the penetration of terms searched, and appropriate ‘‘wild cards”
were used to account for plurals, variations in databases and spel-
ling. Previous reviews included randomized controlled trials, as
well as studies with nonrandomized designs. Because there are
many studies investigating the effect of educational interventions,
in this review only randomized controlled trials were included. An
example search strategy is provided in Supplementary file 1.
Only articles published in English, Dutch or German were con-
sidered. Bibliographies of selected studies and relevant Cochrane
reviews were also hand-searched in order to identify any further
relevant studies not detected by the electronic search.Criteria for considering studies for this review
Studies were selected if the patient population consisted of
adult patients with cancer-related pain. Nociceptive, neuropathic
as well as mixed nociceptive and neuropathic pain were included.
Only studies regarding patients with solid malignancies were
included. All studies describing interventions in which patients
received education about the management of their cancer-related
pain were eligible. We defined educational interventions as infor-
mation, behavioral instructions and advice given for the manage-
ment of cancer-related pain (by verbal, written, audio- or
videotaped or computer-aided modalities), which are given by a
healthcare professional. Interventions aimed only at family care-
givers and studies in which patients’ pain intensity was not self-
reported were excluded. For inclusion of studies, no restraints
regarding the duration of follow-up were made.
The intervention could be compared to no intervention (care as
usual) or an active control intervention (e.g. attention visits or edu-
cation about nutrition).Primary outcomemeasurements considered in this review were
pain intensity and pain interference, measured before and after
intervention. Secondary outcome measures were: knowledge
about cancer-related pain, pain barriers, medication adherence
and self-efficacy.
Study selection
One reviewer conducted the searching and initial screening. A
second reviewer (JG, WO, or IM) independently assessed all titles
with or without abstracts identified by the search. In case of poten-
tially relevant articles, the full text was obtained to judge if they
fulfilled the inclusion criteria. For the articles that met our inclu-
sion criteria, data were extracted independently by two authors
(WO, IM and/or JG), after which extracted data were compared.
All studies were assessed in a standard manner. For each trial
included, information was extracted on study design, number of
patients, length of follow-up, kind of intervention, pain intensity,
knowledge about pain, pain barriers, pain interference with daily
life, medication adherence and self-efficacy.
Assessment of risk of bias in included studies
The quality of each RCT was assessed by two authors (WO, IM)
by examining the risk of bias of each paper based on the adequacy
of randomization, blinding, presence of selective outcome report-
ing, information provided on withdrawals and dropouts and poten-
tial violation of intention-to-treat analysis [16]. Disagreement on
methodological quality was resolved, when necessary, by discus-
sion between these two authors.Results
Characteristics of included studies.
The literature search identified 680 titles. Fig. 1 shows the selec-
tion process. A total of 53 papers was selected for full text assess-
ment. A high level of concordance was achieved as there was
disagreement in only 4 out of 53 papers. These 4 papers were dis-
cussed with two additional authors until consensus was achieved.
Twenty-nine articles fulfilled our inclusion criteria, describing 26
different studies as three studies [17–22] were described in several
articles.
A total of 4735 patients were included. The study population
varied from 30 to 1256 patients at baseline. Twelve studies were
conducted in the USA [18,23–33], eight in Europe [20,21,34–39],
three in Asia [40–42], two in Australia [43,44] and one in Canada
[45].
Most studies (20) included outpatients [18,20,21,23–29,31–33,
35–37,41,43–45], five studies included inpatients [34,38–40,42]
and one study included both inpatients and outpatients [30]. Three
studies included both patients and family caregivers [29,30,41].
In 13 studies, the control group received care as usual [21,24,
27–29,34,36–39,41,43,45], in the other studies an active control
intervention was given (Supplementary Table 1).
Although the interventions varied widely in content and inten-
sity, 22 out of the 26 (85%) studies provided face-to-face sessions
with the patients; 19 of these studies provided repeated contacts:
four studies several face-to-face sessions and additional phone
calls, five studies only repeated face-to-face sessions, and ten stud-
ies one face-to-face contact and additional phone calls. Seventeen
studies combined these sessions with a booklet or video. The three
studies without face-to-face contacts provided a booklet and/ or
educational video supplemented with phone calls in two of them.
Follow-up varied from 5 days to 6 months (median 8 weeks)
(Supplementary Table 1).
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almost all studies had problems with blinding of the treatment
allocation, (the participants and/or providers and/or outcome
assessors). Overall, the majority of the studies reported most mea-
sured outcomes. However, three studies are very likely to have a
bias here [24,41,43]. Due to the heterogeneity in study design, type
of intervention, and the outcome measures, it was not possible to
pool the results of the studies.
Primary outcomes
Pain intensity
All studies measured patients’ pain intensity. Most studies
reported on worst and average pain [18,20,21,25,26,30,34,35,40,4
3,45]. Composite scores were used by Kravitz (mean of worst and
usual pain), Ward (2008, 2009-1 and 2009-2) (mean of worst, least
and current pain) and Williams (mean of worst, least, current and
usual pain). The remaining studies measured another type of painFig. 1. Prisma flointensity (e.g. current pain) or did not specify what type of pain
intensity was measured (Table 1).
A 0–10 Numeric Rating Scale (NRS) was used in 22 of the 26
studies and a 0–100 Visual Analogue Scale (VAS) in two studies
[31,33]. Two studies used a combination of a 0–10 NRS and a 4
or 5-point Likert scale [29,39]. One study reported only on pain
relief on a 0–100 NRS [32].
Eight of the 26 studies (31%) reported a statistically significant
difference in pain intensity in favor of the intervention group
[18,21,25,39–41,43,45]. However, these studies measured pain
intensity in different ways; average pain intensity (six studies),
worst pain intensity (four studies), current pain intensity (three
studies), and least pain intensity (two studies; Table 1). These eight
studies included 19% of all included patients. In six out of these
eight studies, the intervention existed of a face-to-face session
(nurse-led in five studies), followed by repeated face-to-face ses-
sions (n = 4) or follow-up phone calls (n = 2). All studies provided
written and/or videotaped information. The control group receivedw diagram.
Table 1
Summary of the difference in main outcomes between the different groups of the included RCTs.
Study Intervention Number of patients:
total (inter- vention)
Follow-up PID average
pain intensity
PID worst
pain intensity
PID pain intensity
others
Knowledge
about pain
Pain barriers Pain interference
with daily life
Medication adherence Self-efficacy
Anderson (2004) Video + booklet 97 (50) 10 weeks – BPI (0–10)
DNR; NS
– SPA
DNR; NS
– BPI (0–10)
DNR; NS
Self-reported adherence
14%; NS
–
Jahn (2014) SCION-PAIN 263 (128) 1 week BPI (0–10)
DNR; NS
BPI (0–10)
DNR; NS
BQ II
0.49 (CI 0.87 to
0.12) p = .02
MAS
Better adherence in
intervention group, p = .02
DNR
–
Koller (2013) PRO-SELF 39 (19) 22 weeks BPI (0–10)-0.51
(CI: 1.95 to
0.94); NS
BPI (0–10)-
0.47
(CI: 2.81 to
1.87); NS
PPQ (0–10)
22%; P < .01
– BPI (0–10)
1.5; (P = .02)
– SEQ (Null-100)
7.3; NS
Kravitz (2012) Tailored education and
coaching
307 (150) 12 weeks 0–10 scale
Composite scale:
DNR; NS
– SBQ
0.02; NS
– – CPSE (2 weeks)
Communication
0.22, P < .001
Pain control:
0.03, NS
Lai (2004) Patient Education
Program
30 (15) 5 days BPI (0–10)
1.6
P < .05
BPI (0–10)
0.13
NS
BPI (0–10)
Current pain: 1.93;
P < .05
POABS-CA
1.09
P < .005
BPI (0–10)
.76
NS
– –
Lin (2006) Pain education program 61 (31) 4 weeks BPI (0–10)
DNR
BPI (0–10)
1.33;
P = .04
– BQ-T
0.78 (P < .0001)
BPI (0–10)
1.24
(P = .03)
MAS (0–4)
1.78
P < .0001
Use of pain medication:
0.16; P = 0.05
–
Lovell (2010) Video + booklet 217 (163) 4 weeks BPI (0–10)
1.17; P = .02
BPI (0–10)
1.12; P < .05
– – BQ
0.13; NS
BPI (0–4)
DNR
– –
Miaskowski (2004)/Kim
(2004)
PRO-SELF 174 (93) 6 weeks NRS (0–10)
34%
P < .001
NRS (0–10)
26%
P < .001
NRS (0–10)
Least pain:
43% P < .001
FPPQ (0–
100)
12.7; P <
.001
– Diary
25% increase vs. 9.0%; NS
–
Oldenmenger (2011)/
Oldenmenger (2017)
PC-PEP 73 (35) 8 weeks BPI (0–10)
31% vs. 20%
P = .03
BPI (0–10)
0.12
NS
BPI (0–10)
Current pain: 30%
vs. 16%, P = .016
FPPQ (0–100)
7; P = .002
– BPI (0–10)
20% vs.2.5%;
P = .01
MEMS
9%;
P = .028
–
van der Peet (2009) PEP 120 (58) 8 weeks – BPI (0–10)
Current pain:
0.9; NS
FPPQ (0–100)
DNR;
P < .001
– – – –
Rustøen (2012)/(2013) PRO-SELF 179 (87) 6 weeks NRS (0–10)
DNR; NS
NRS (0–10)
DNR; NS
PES
18.5;
P < .001
– – – –
Smith (2010) PECS 89 (47) 12 weeks – BPI pain relief (0–
100%)
5.1; NS
– BQ
10.5;
P = .04
– – –
Syrjala (2008) Patient training 93 (48) 6 months BPI (0–10)
0.81 ± 0.36
P = .03
BPI (0–10)
0.27 ± 0.38
NS
BQ
0.32 ± 0.09
P < .001
BPI (0–10)
0.62 ± 0.38 NS
– –
Thomas (2012) Education or coaching 317 (103); (105) 6 months BPI (0–10)
DNR; NS
BPI (0–10)
DNR; NS
BQ
DNR; NS
0–10 scale
DNR
P = .02
– –
Tse (2012) PMP 43 (22) 1 week – – NRS (0–10)
0.72; NS
– BQ-T
Total score DNR;
NS
– – –
Vallieres (2006) Intervention session +
pain diary
64 (33) 3 weeks NRS (0–10)
2.2
P = .01
NRS (0–10)
1.7
NS
– – – – –
Ward (2008) RID Cancer Pain 176 (92) 2 months – BPI (0–10)
0.17; NS
– BQ-r (0–5)
0.07
P = .025
BPI (0–10)
0.26; NS
– –
Ward (2009_1) TBI 1256 (391) 4 weeks – BPI (0–10)
composite scale
0.13; NS
– BQ-II
DNR
P < .001
BPI (0–10)
NS
– –
Ward (2009_2) 1 dyads and 2 solo 161 (104) 9 weeks – BPI (0–10)
1.49; NS
– BQ-II
Dyads vs control
0.64
P = .001
Solo vs control
0.38 p = .018
BPI (0–10)
0.03; NS
– –
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100 W.H. Oldenmenger et al. / Cancer Treatment Reviews 63 (2018) 96–103care as usual in five studies. In all but one study, the follow-up was
 8 weeks (Supplementary Table 1).Pain interference
Twelve studies investigated pain interference with daily life [2
1,23,26–30,35,40,41,43,44]. Ten of these studies reported interfer-
ence on a 0–10 NRS scale, measured with the Brief Pain Inventory
(BPI). Two studies used an adapted version to measure interference
(Table 1).
Four studies (33%) found a statistically significant difference
between the intervention and the control group [21,32,35,41].
Two of these studies also found a significant difference in pain
intensity (Table 1) [21,41].Secondary outcomes
Knowledge about cancer-related pain/pain barriers
Twenty-two studies (85%) reported on pain knowledge and/or
pain barriers. A version of the Barriers Questionnaire (BQ) was used
in 14 studies (Table 1). Fifteen studies (68%) showed a significant
difference in pain knowledge or barriers (increased knowledge or
less barriers; Table 1). In all these studies, the intervention existed
of a face-to-face session (nurse-led in 11 studies), followed by
repeated face-to-face sessions and/or follow-up phone calls in 14
studies. Twelve studies provided written and/or videotaped infor-
mation. The control group received care as usual in nine studies.
In 11 studies, the follow-up was  8 weeks (Supplementary
Table 1).
Seven out of the eight studies that reported a statistically signif-
icant difference in pain intensity, also measured pain knowledge or
barriers, in which six studies found a statistically significant differ-
ence (Table 1).Medication adherence
Six studies reported on medication adherence (Table 1). All
studies measured medication adherence in a different way. Two
studies used a questionnaire: the Medication Adherence Scale
[34,41]. Four studies used patients’ self-report: in one study
patients were questioned whether they used the prescribed anal-
gesics [23,31], in one study a diary was used [18], and one study
measured actual use with the Medication Event Monitoring System
[21].
Three studies (50%) found a statistically significant increase of
medication adherence in the intervention group [21,34,41], of
which two (33%) also found a statistically significant difference
in pain intensity (Table 1) [21,41].Self-efficacy
Two studies reported on self-efficacy measured with a ques-
tionnaire (Table 1). Kravitz et al. measured self-efficacy after only
2 weeks and found a statistically significant difference on self-
efficacy regarding communication [24]. There were no significant
differences between the groups regarding pain-control and self-
efficacy (Table 1).
None of the included studies reported on all outcome measure-
ments. Four studies reported four of the five selected outcome
measurements [21,23,35,41]. One study found no statistically sig-
nificant differences in any outcome measurement [23]. Another
study found statistically significant differences in pain knowledge
and pain interference, with no significant differences in pain inten-
sity and self-efficacy [35]. Two studies found statistically signifi-
cant differences in all reported outcomes: pain intensity, pain
interference, pain knowledge or pain barriers and medication
adherence [21,41].
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This systematic review of 26 randomized controlled trials
shows that in eight studies (31%) including 19% of all included
patients, education has a statistically significant effect on reported
pain. None of the included studies reported all pre-defined out-
come measurements. Significant improvements in daily pain inter-
ference were found in 33% of the studies. A statistically significant
improvement in patients’ knowledge was reported in 66% of the
studies. Medication adherence and self-efficacy were reported inTable 2
Risk of bias for the included randomized controlled trials.
Study 
reference
(ﬁrst author, 
publicaon 
year)
Describe method of 
randomisaon1
Bias due to 
inadequate  
concealment of 
allocaon?2
(unlikely/likely/
unclear)
Bias due to inadequate 
blinding of parcipants 
to treatment 
allocaon?3
(unlikely/likely/unclear)
Bias due to inadequate 
blinding of care 
providers to treatment 
allocaon?3
(unlikely/likely/unclear)
Anderson, 
2004
Not described Unclear Unclear Unclear
Jahn, 2014 1) Pair-matched 
randomizaon of 2 paents 
on a ward 2) concurrently on 
all wards prior to study 3) by 
a reproducible SAS PROC 
PLAN 4) by an external 
department
Unlikely Likely Likely
Koller, 2013 Computerized permuted 
blocks procedure, 1:1. 
Sequenally numbered 
opaque envelopes
Unlikely Likely Unlikely
Kravitz, 2012 Computer-generated 
blocked randomizaon
Unlikely Likely Likely
Lai, 2004 Not reported Unclear Unclear Unclear
Lin, 2006 “randomly assigned” Unclear Unclear Unclear
Lovell, 2010 Central randomizaon by 
telephone: random numbers 
table
Unlikely Likely Likely
Miaskowski, 
2004/ Kim 
2004
“randomly assigned” Unclear Unlikely Unlikely
Oldenmenger, 
2011
Computer-generated 
randomizaon procedure 
with variable block length 
(1-4 repeon blocks)
Unlikely Unclear Unclear
Van der Peet, 
2009
Computer-generated 
randomizaon procedure
Unlikely Unclear Unclear
Rustøen, 
2012/2013
Randomized by lot Likely Unclear Unclear
Smith, 2009 Randomizaon ulity 
roune in SPSS
Unlikely Unclear Unclear
Syrjala, 2007 Randomly assigned in blocks 
based on straﬁcaons
Unlikely Likely Likely
Thomas, 2012 Permuted blocks with 
variable sizes
Unlikely Unlikely Unlikely
Tse, 2012 Not reported Unclear Unclear Unclear
Vallieres, 
2006
Randomly assigned (no 
further descripon)
Unclear Unclear Unclear
Ward, 2008 Excel’s RAND funcon Unlikely Likely Likely
Ward, 2009_1 Not reported Unclear Unclear Unclear
Ward, 2009_2 Excel’s RAND funcon in 
repeang blocks of 30
Unclear Likely Likely
Wells, 2003 Not reported Unclear Likely Likely
Wilkie, 2010 Sequenally numbered 
opaque envelopes
Unlikely Likely Unlikely
Williams, 
2015
Randomizaon was 
performed in blocks based 
on straﬁcaons
Unlikely Likely Unclear 
De Wit, 1997 Not reported Unclear Unclear Unclear
Wright Oliver, 
2001
Randomizaon in blocks of 
20
Unclear Unclear Unclear
Yates, 2003 Computer-generated table 
of random numbers
Likely Likely Likely
Yildirim, 2009 Not described Unclear Unclear Unclear
1 Randomization: generation of allocation sequences have to be unpredictable, for examp
inadequate procedures are generation of allocation sequences by alternation, according
2 Allocation concealment: refers to the protection (blinding) of the randomization pr
investigators cannot foresee assignment, for example central randomization (performe
envelopes. Inadequate procedures are all procedures based on inadequate randomizatio
3 Blinding: neither the patient nor the care provider (attending physician) knows whi
example when comparing surgical with non-surgical treatments. The outcome assessor
knowledge of patient assignment influences the process of outcome assessment (detectio
blinding of outcome assessment is not necessary. If a study has ‘‘soft” (subjective) outc
necessary.
4 Results of all predefined outcomemeasures should be reported; if the protocol is availab
outcomes listed in the methods section of an article can be compared with those whose
5 If the percentage of patients lost to follow-up is large, or differs between treatment g
likely. If the number of patients lost to follow-up, or the reasons why, are not reported,
6 Participants included in the analysis are exactly those who were randomized into the tri
the risk of bias is unclear; an ITT analysis implies that (a) participants are kept in the inte
actually received, (b) outcome data are measured on all participants, and (c) all randomonly six and three of the included RCTs, respectively. The included
studies were too heterogeneous to prove their effects.
Heterogeneousness was seen in the educational interventions,
control interventions, lengths of follow-up and reported outcome
measures. The educational interventions varied in content, inten-
sity and duration. Some interventions existed of only written
and/or audio-visual information, while other interventions com-
bined this information with single or multiple face-to-face sessions
or follow-up phone calls. The interventions were not always clearly
described (Supplementary Table 1), so it was hard to seeBias due to inadequate 
blinding of outcome 
assessors to treatment 
allocaon?3
(unlikely/likely/unclear)
Bias due to selecve 
outcome reporng on 
basis of the results?4
(unlikely/likely/unclear)
Bias due to loss to 
follow-up?5
(unlikely/likely/unclear)
Bias due to violaon of 
intenon to treat 
analysis?6
(unlikely/likely/unclear)
Unlikely Unlikely Unlikely Unlikely
Unclear Unlikely Unlikely Unlikely
Unclear Unlikely Unclear Unlikely
Unclear Likely Unlikely Unlikely
Unclear Unlikely Unclear Unclear
Unclear Likely Unclear Unclear
Likely Likely Unlikely Unclear   
Unlikely Unlikely Unlikely Unclear
Unclear Unlikely Unlikely Unclear
Unclear Unlikely Likely Unclear
Unclear Unclear Unlikely Unlikely
Unlikely Unlikely Unlikely Unclear
Likely Unlikely Likely Likely
Unlikely Unlikely Likely Unclear
Unclear Unlikely Unlikely Likely
Unclear Unlikely Unclear Unclear
Likely Unlikely Unlikely Unclear
Unclear Unlikely Unlikely Unclear
Likely Unlikely Unlikely Unclear
Likely Unlikely Unclear Unclear
Unclear Unlikely Unclear Unclear 
Unclear Unlikely Unlikely Unclear 
Unclear Unlikely Likely Unclear
Unlikely Unlikely Unclear Unclear
Likely Unlikely Unlikely Unlikely
Unclear Unlikely Unclear Unclear
le computer generated random-numbers or drawing lots or envelopes. Examples of
to case record number, date of birth or date of admission.
ocess. Concealment of allocation sequences is adequate if patients and enrolling
d at a site remote from trial location) or sequentially numbered, sealed, opaque
n procedures or open allocation schedules.
ch patient is getting the special treatment. Blinding is sometimes impossible, for
records the study results. Blinding of those assessing outcomes prevents that the
n or information bias). If a study has hard (objective) outcome measures, like death,
ome measures, like the assessment of an X-ray, blinding of outcome assessment is
le, then outcomes in the protocol and published report can be compared; if not, then
results are reported.
roups, or the reasons for loss to follow-up differ between treatment groups, bias is
the risk of bias is unclear
al. If the numbers randomized into each intervention group are not clearly reported,
rvention groups to which they were randomized, regardless of the intervention they
ized participants are included in the analysis.
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interventions differed from care as usual to friendly visits or edu-
cational interventions regarding nutrition. The length of follow-
up also varied widely, from 5 days to 6 months.
Although patients’ pain intensity was measured in all included
studies, the way this was reported varied widely. Different types
of pain intensity were reported (e.g. average, worst, current, least
pain intensity or combinations of these types), and with different
time frames (e.g. at this moment, last 24 h or last two weeks;
Supplementary table 1). Besides this, different methods to
measure pain intensity were used (Table 1). This variation was
previously reported in several articles, and these articles were
calling for more standardization in outcome measurements
[11,46,47], but, as our present review shows, in the more recent
studies there is still no improvement in standardization of
outcome measurements.
We included interference of pain with daily activities also
as a primary outcome. To our opinion it is not only important
to evaluate patients’ pain intensity, but also the impact of
pain on daily life. Improved pain management can be
achieved by a lower pain intensity, or by lower interference
with the same pain intensity, making it possible for patients
to increase their daily. This should be an important topic in
patients’ pain education, because it is not only important to
decrease patients’ pain intensity but also to improve their
daily activities.
It is a common theory that improvements in patients’ pain
knowledge lead to improved self-efficacy and medication adher-
ence, and ultimately lead to reductions in patients’ pain intensity
[15,42,44]. However, in the 88% of the included RCTs reporting
data regarding pain knowledge and/ or barriers, we were not able
to find a relation with pain intensity nor adherence. Medication
adherence was measured in different ways, with a questionnaire,
a single statement, and the measurement of the actual analgesic
use (Table 1). As described by Oldenmenger et al. [22], these
adherence rates should be interpreted in different ways. There-
fore, it is hard to compare adherence rates when different meth-
ods were used [22]. Moreover, most studies only reported
whether patients took their medication (taking adherence), with-
out giving details on the analgesic use during the day (e.g. with
the right intervals, timing adherence). In the paper by Olden-
menger et al. [22] on adherence to analgesics in oncology outpa-
tients, the authors concluded that the true problem considering
adherence is that patients do not take their pain medication at
the right time intervals. This finding is an argument for education
and coaching of patients to take their analgesics more regularly
using correct dosing intervals [22].
Because most patients with cancer-related pain stay at home,
they are expected to have an active and involved role in the mon-
itoring of and communication about their symptoms. With
patients’ pain education, nurses may stimulate patients’ self-
efficacy. However, almost none of the included RCTs have mea-
sured the effect of pain education on patients’ self-efficacy. Future
studies should include self-efficacy as a process variable.
Over the years, different reviews on the effectiveness of patient
educational interventions were published [3,10,11,13,14]. All these
reviews included RCTs as well as studies with other designs, like
(quasi-) experimental or pre-posttest designs. In one review, vari-
ous articles describing different outcomes of the same study were
included as separate studies [14]. In this review, the investigators
found a significant decrease of pain intensity in 52% of all included
studies [14], much more than the 31% of the included studies in
our review. An explanation of this discrepancy could be the inclu-
sion of non-randomized studies in their review, as five out of the
six non-randomized studies showed a significant decrease in pain
intensity.In the review of Koller et al. [13], educational interventions
were categorized into structure and content components and
evaluated their efficacy. No single component, or combination
of components were found to have a discernible influence on
effect sizes. After their review, only one RCT was published
reporting a significant decrease in pain intensity [21]. It remains
unclear which components or aspects of educational interven-
tions contribute to a decrease in pain intensity. It is remarkable
that of the seven RCTs published after 2011 and included in our
review, none reported a significant decrease in pain intensity. It
is imaginable that over the years, the quality of standard care is
improved. This is illustrated by a decrease in pain intensity in
both the intervention and the control group in four of these RCTs
[26,35,37,42] and the improvement of adequate prescription of
analgesics. Three studies investigated the adequacy of analgesic
prescription, measured with the Pain Management Index (PMI)
[18,21,37]. Miaskowski et al. reported in 2004 an adequate pre-
scription of opioids in 29% of the patients at baseline and 37%
in the intervention group at the end of the study [18]. In 2011,
Oldenmenger et al. reported that about 61% of the patients had
an adequate opioid prescription at baseline [21]. In 2015, Wil-
liams et al. reported an adequate opioid prescription of 45–49%
at baseline [37].
Strengths and limitations
To our knowledge this is the first systematic review that stud-
ies the effect of pain education in patients with cancer-related
pain, and provides a clear overview of the risk of bias of these
studies. Because of the earlier described heterogeneity, in both
the intervention and outcome measurements, it was not possible
to pool the results and perform a meta-analysis. The strength of
this review is that only RCT’s were included, with all relevant out-
comes of patient pain education programs, to give a clear over-
view of the existing evidence. This systematic review described
an improvement in pain intensity in 31% of the studies. An expla-
nation for this is the possible contamination of the control group
[21], whereby the actual effect of the pain education programs
could be much larger. The interpretation of the results of this
review is complicated by differences in the quality of the included
RCTs. It is striking that in so many RCTs the methodology was
unclearly described and therefore the risk of bias was hard to
assess. For educational programs it is hard to adhere to all crite-
ria, and therefore we decided not to score the quality of the RCTs
nor to exclude studies based on their risk of bias, but to give an
overview of the risk of bias. In the future, authors should report
the used methodology better, regarding both the interventions
and the outcome measurements.
In conclusion, patient pain education programs can improve
patients’ knowledge about cancer-related pain. However, because
of the heterogeneity of both the description of the intervention
as the outcome measurements’, the effect of education programs
on pain intensity and interference of pain with daily activities
remains unclear, and no recommendation on types of interventions
can be made. A more standardized reporting should be advised in
order to enlarge the study populations and to strengthen the
evidence.
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